Metabolism and clinical pharmacokinetics of 2-methyl-n-(2′-(pyrrolidinyl-1-ylsulfonyl)-n-[1,1′-biphenyl]-4-yl)propran-1-amine: insights into monoamine oxidase- and CYP-mediated disposition by integration of in vitro ADME tools

By Sawant Basak Aarti   Byon Wonkyung   Tseng-Lovering Elaine   Funk Carrie   Wood Linda   Lin Chang   Delnomdedieu Marielle   Verhoest Patrick   Parikh Vinod   Cox Loretta M.   Miller Emily   Gao Hongying   Obach Ronald S.  

Xenobiotica, Vol. 44, Iss. 5, 2014-05 ,pp. : 438-454

Informa Healthcare

Access to resources Recommend Favorite

In vitro and in vivo metabolism of a novel cannabinoid-1 receptor inverse agonist, taranabant, in rats and monkeys

By Reddy V.B.G.   Doss G.A.   Karanam B.V.   Samuel K.   Lanza Jr T.J.   Lin L.S.   Yu N.X.   Zhang A.S.   Raab C.E.   Stearns R.A.   Kumar S.  

Xenobiotica, Vol. 40, Iss. 9, 2010-09 ,pp. : 650-662

Informa Healthcare

Access to resources Recommend Favorite

In vitro and in vivo studies on the stereoselective pharmacokinetics and biotransformation of an (S)-(-)- and (R)-(+)-pyrazolotriazine sulfoxide in the male rat

By Naito S.   Nishimura M.  

Xenobiotica, Vol. 32, Iss. 6, 2002-06 ,pp. : 491-503

Informa Healthcare

Access to resources Recommend Favorite

In vitro inhibition and induction of human cytochrome P450 enzymes by mirabegron, a potent and selective β3-adrenoceptor agonist

By Takusagawa Shin   Miyashita Aiji   Iwatsubo Takafumi   Usui Takashi  

Xenobiotica, Vol. 42, Iss. 12, 2012-12 ,pp. : 1187-1196

Informa Healthcare

Access to resources Recommend Favorite

In vitro model for the prediction of clinical CYP3A4 induction using HepaRG cells

By Kaneko A.   Kato M.   Sekiguchi N.   Mitsui T.   Takeda K.   Aso Y.  

Xenobiotica, Vol. 39, Iss. 11, 2009-11 ,pp. : 803-810

Informa Healthcare

Access to resources Recommend Favorite